These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 19108402)

  • 21. Quality measures.
    Nicholas RL
    CAP Today; 2005 Aug; 19(8):8. PubMed ID: 16164172
    [No Abstract]   [Full Text] [Related]  

  • 22. Laboratory clinical effectiveness: pathologists improving clinical outcomes.
    Schuerch C; Selna M; Jones J
    Clin Lab Med; 2008 Jun; 28(2):223-44, vi. PubMed ID: 18436068
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In-house daily consensus conference: an important quality control/quality assurance activity--experience at a major referral center.
    Khurshid A; Ahmad Z; Qureshi A
    Indian J Pathol Microbiol; 2009; 52(3):325-7. PubMed ID: 19679952
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Guidelines for Clinical Pathology/Laboratory Medicine of Cardiology of the Brazilian Society of Cardiology].
    Lima JC; Silva AM; Lima AP; Balarrati CA; Sá E; Lima JC; Souza LE; Padovani R; Shcolnik W; Guimarães JI;
    Arq Bras Cardiol; 2003 Dec; 81 Suppl 7():1-4. PubMed ID: 15011681
    [No Abstract]   [Full Text] [Related]  

  • 25. [The clinical molecular pathologist: beyond the image].
    van Noesel CJ
    Ned Tijdschr Geneeskd; 2011; 155(18):A2971. PubMed ID: 21466725
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nordic immunohistochemical quality control.
    Vyberg M; Torlakovic E; Seidal T; Risberg B; Helin H; Nielsen S
    Croat Med J; 2005 Jun; 46(3):368-71. PubMed ID: 15861513
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Analytic Validation of Immunohistochemical Assays: A Comparison of Laboratory Practices Before and After Introduction of an Evidence-Based Guideline.
    Fitzgibbons PL; Goldsmith JD; Souers RJ; Fatheree LA; Volmar KE; Stuart LN; Nowak JA; Astles JR; Nakhleh RE
    Arch Pathol Lab Med; 2017 Sep; 141(9):1247-1254. PubMed ID: 28557617
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Pathology Laboratory Act 2007 explained.
    Looi LM
    Malays J Pathol; 2008 Jun; 30(1):1-10. PubMed ID: 19108405
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Virtual slide telepathology for an academic teaching hospital surgical pathology quality assurance program.
    Graham AR; Bhattacharyya AK; Scott KM; Lian F; Grasso LL; Richter LC; Carpenter JB; Chiang S; Henderson JT; Lopez AM; Barker GP; Weinstein RS
    Hum Pathol; 2009 Aug; 40(8):1129-36. PubMed ID: 19540562
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The BSCC code of practice--exfoliative cytopathology (excluding gynaecological cytopathology).
    Chandra A; Cross P; Denton K; Giles T; Hemming D; Payne C; Wilson A; Wilson P
    Cytopathology; 2009 Aug; 20(4):211-23. PubMed ID: 19659955
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunohistochemical Validation of Rare Tissues and Antigens With Low Frequency of Occurrence: Recommendations From The Anatomic Pathology Patient Interest Association (APPIA).
    Lott RL; Riccelli PV; Sheppard EA; Wharton KA; Walk EE; Kennedy G; Portier B
    Appl Immunohistochem Mol Morphol; 2021 May-Jun 01; 29(5):327-334. PubMed ID: 32324630
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regulatory agencies involved with the clinical laboratory.
    Passiment E
    Clin Lab Sci; 2006; 19(1):43-9. PubMed ID: 16617557
    [No Abstract]   [Full Text] [Related]  

  • 33. CD34-reactive tumors of the skin. An updated review of an ever-growing list of lesions.
    Tardío JC
    J Cutan Pathol; 2009 Jan; 36(1):89-102. PubMed ID: 19125742
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Avoiding pitfalls in diagnostic immunohistochemistry-important technical aspects that every pathologist should know.
    Miller RT
    Semin Diagn Pathol; 2019 Sep; 36(5):312-335. PubMed ID: 31227425
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Informatics tools for quality in anatomic pathology.
    Prichard JW; Strevig G; Brown AM; Wilkerson ML
    Clin Lab Med; 2008 Jun; 28(2):207-22, vi. PubMed ID: 18436067
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Value of immunohistochemistry in uterine pathology: common and rare diagnostic dilemmas.
    Giordano G
    Pathol Res Pract; 2009; 205(10):663-76. PubMed ID: 19523774
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Usefulness of immunohistochemistry for differential diagnosis between benign and malignant breast lesions.
    Moriya T; Kanomata N; Kozuka Y; Fukumoto M; Iwachido N; Hata S; Takahashi Y; Miura H; Ishida K; Watanabe M
    Breast Cancer; 2009; 16(3):173-8. PubMed ID: 19475479
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Technico-biological problems in immunohistochemical study of oral lesions].
    Serpico R; Laino G; Lamparelli A
    Arch Stomatol (Napoli); 1990; 31(1):153-6. PubMed ID: 2291705
    [No Abstract]   [Full Text] [Related]  

  • 39. Fit-for-Purpose Immunohistochemical Biomarkers.
    Torlakovic EE
    Endocr Pathol; 2018 Jun; 29(2):199-205. PubMed ID: 29696583
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The immunohistochemistry of solid tumours: potential problems for new laboratories.
    Pillai R; Kannan S; Chandran GJ
    Natl Med J India; 1993; 6(2):71-5. PubMed ID: 8477213
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.